版本:
中国

BRIEF-Kadmon submits 2nd abbreviated new drug application filing for trientine hydrochloride to FDA

April 4 Kadmon Holdings Inc:

* Kadmon submits second abbreviated new drug application filing for trientine hydrochloride to FDA

* Kadmon Holdings Inc - product to offer room temperature storage, representing advantage over currently marketed formulations Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐